Avai Bio, Inc.
AVAI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.12M
Close$
$-0.01
112.2% downside
Current Fair Value
112.2% downsideOvervalued by 112.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $16.12 Million |
|---|---|
| Enterprise Value | $18.32 Million |
| Earnings per Share | $-0.01 |
| Beta | 0.95 |
| Outstanding Shares | 153,916,565 |
Return
| Return on Equity | 56.29% |
|---|---|
| Return on Assets | -229.11% |
| Return on Invested Capital | 18.94% |
Valuation & Multiples
| P/E Ratio | -7.95 |
|---|---|
| PEG | -60.16 |
| Price to Sales | - |
| Price to Book Ratio | -0.1 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -30.01 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | -0.71 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Avai Bio, Inc.
1 employees
CEO: Chris Winter
Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and ma...